CME Group Inc. (NASDAQ:CME) Shares Bought by Legacy Advisors LLC

Legacy Advisors LLC boosted its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 14.8% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,674 shares of the financial services provider's stock after buying an additional 1,117 shares during the quarter. Legacy Advisors LLC's holdings in CME Group were worth $2,301,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. New Age Alpha Advisors LLC boosted its position in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares in the last quarter. Knuff & Co LLC acquired a new stake in CME Group in the 4th quarter valued at about $33,000. Banque Transatlantique SA acquired a new stake in CME Group in the 4th quarter valued at about $35,000. Whipplewood Advisors LLC purchased a new position in CME Group during the 4th quarter valued at about $37,000. Finally, United Community Bank acquired a new position in CME Group during the fourth quarter worth about $37,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at CME Group

In related news, Director Daniel G. Kaye sold 500 shares of the firm's stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the sale, the director now directly owns 3,668 shares of the company's stock, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 300 shares of the business's stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $273.17, for a total transaction of $81,951.00. Following the completion of the transaction, the director now owns 24,767 shares in the company, valued at $6,765,601.39. This represents a 1.20% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,400 shares of company stock worth $3,680,610. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CME. Barclays lifted their price objective on CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. Oppenheimer increased their price objective on CME Group from $282.00 to $300.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Bank of America upped their target price on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a report on Wednesday, April 2nd. Finally, Raymond James Financial upgraded shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price target for the company in a report on Monday, March 10th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $258.20.

CME Group Trading Down 0.5%

Shares of CME Group stock traded down $1.28 during trading hours on Tuesday, reaching $271.38. The stock had a trading volume of 2,088,928 shares, compared to its average volume of 2,225,801. The firm has a market capitalization of $97.79 billion, a price-to-earnings ratio of 27.30, a P/E/G ratio of 3.72 and a beta of 0.45. CME Group Inc. has a 1 year low of $192.11 and a 1 year high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a 50 day simple moving average of $274.35 and a two-hundred day simple moving average of $255.81.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The firm had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company's revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.50 EPS. As a group, equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.84%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's dividend payout ratio is presently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.